Medpace (MEDP) Earnings Date, Estimates & Call Transcripts $343.96 +6.21 (+1.84%) (As of 08:01 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Medpace Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 10EstimatedActual EPS (Oct. 21) $3.01 Beat By $0.24 Consensus EPS (Oct. 21) $2.77 Medpace issued Q3 2024 earnings on October 21, 2024, reporting an EPS of $3.01, which beat analysts' consensus estimates of $2.77 by $0.24. Quarterly revenue rose 8.3% year-over-year to $533.32 million, below the consensus estimate of $540.99 million. With a trailing EPS of $11.42 and a P/E Ratio of 30.12, Medpace's earnings are expected to grow 3.27% next year, from $11.93 to $12.32 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingMEDP Upcoming EarningsMedpace's next earnings date is estimated for Monday, February 10, 2025, based off prior year's reporting schedules. Get Medpace Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medpace and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMEDP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MEDP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now Medpace Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$2.08$2.45$2.27 Q2 20242$2.01$2.49$2.25 Q3 20242$2.28$2.74$2.51 Q4 20242$2.56$2.87$2.72 FY 20248$8.93$10.55$9.74 Q1 20251$2.92$2.92$2.92 Q2 20251$3.06$3.06$3.06 Q3 20251$3.18$3.18$3.18 Q4 20251$3.19$3.19$3.19 FY 20254$12.35$12.35 $12.35 Medpace Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/10/2025(Estimated)------- 10/21/2024Q3 2024$2.77$3.01+$0.24$3.01$540.99M$533.32M 7/22/2024Q2 2024$2.54$2.75+$0.21$2.75$528.41M$528.10M 4/22/2024Q1 2024$2.45$3.20+$0.75$3.20$512.39M$511.00M 2/12/2024Q4 2023$2.22$2.46+$0.24$2.46$498.72M$498.40M 10/23/2023Q3 2023$2.05$2.22+$0.17$2.22$475.79M$492.50M 7/24/2023Q2 2023$1.90$1.93+$0.03$1.93$433.75M$460.90M 2025: Digital Asset Insights You Need to Know (Ad)Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today!4/24/2023Q1 2023$1.76$2.27+$0.51$2.27$402.83M$434.07M 2/13/2023Q4 2022$1.78$2.12+$0.34$2.12$386.09M$394.10M Medpace Earnings - Frequently Asked Questions When is Medpace's earnings date? Medpace has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 10th, 2025 based off last year's report dates. Learn more on MEDP's earnings history. What guidance has Medpace issued on next quarter's earnings? Medpace issued an update on its FY 2024 earnings guidance on Monday, October, 21st. The company provided earnings per share (EPS) guidance of 11.710-12.090 for the period, compared to the consensus earnings per share estimate of 11.560. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion. Did Medpace beat their earnings estimates last quarter? In the previous quarter, Medpace (NASDAQ:MEDP) reported $3.01 earnings per share (EPS) to beat the analysts' consensus estimate of $2.77 by $0.24. Learn more on analysts' earnings estimate vs. MEDP's actual earnings. How can I listen to Medpace's earnings conference call? The conference call for Medpace's latest earnings report can be listened to online. Listen to Conference Call How can I read Medpace's conference call transcript? The conference call transcript for Medpace's latest earnings report can be read online. Read Transcript How can I view Medpace's earnings report? Medpace's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Medpace generate each year? Medpace (NASDAQ:MEDP) has a recorded annual revenue of $1.89 billion. How much profit does Medpace generate each year? Medpace (NASDAQ:MEDP) has a recorded net income of $282.81 million. MEDP has generated $11.42 earnings per share over the last four quarters. What is Medpace's price-to-earnings ratio? Medpace (NASDAQ:MEDP) has a trailing price-to-earnings ratio of 30.31 and a forward price-to-earnings ratio of 29.02. The price/earnings-to-growth ratio is 1.87. What is Medpace's EPS forecast for next year? Medpace's earnings are expected to grow from $11.93 per share to $12.32 per share in the next year, which is a 3.27% increase. ` More Earnings Resources from MarketBeat Related Companies TCOM Earnings IQV Earnings CPAY Earnings GIB Earnings RDDT Earnings KSPI Earnings GRAB Earnings TOST Earnings TRU Earnings Z Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now This page (NASDAQ:MEDP) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
